Parkinson'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For those who meet all of the following (1) Diagnosed as Parkinson's disease based on UK Parkinson's Disease Society Brain Bank criteria (2) Stable antiparkinson drug regimen for at least 4 weeks prior to study entry (3) Stages <=3 in the ON state for Modified Hoehn and Yahr Scale (4) People who have given written consent
Exclusion criteria
Exclusion criteria: Exclude any person who also corresponds to one of the following (1) History of severe neurological diseases such as dementia, visual impairment, psychiatric disorders (2) Those who have severe cardiopulmonary disorder (3) Walking in daily life is not independent (4) People who are in the Investigator's judgment unlikely to comply with medical regimens or study requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) step counts at pre and post intervention (6 month) | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) indicator of Parkinson's disease symptoms (motor symptoms, non-motor symptoms) (2) drug regimen (3) cognitive function (attention, executive function, processing speed, etc.) (4) physical and mental performance and physical activity (5) psychological outcomes (6) daily life performance outcomes (7) biomarker | — |
Countries
Japan
Contacts
Fukuoka University Graduate School of Medicine Department of Neurology and Neurological Science